This review emphasizes that integrating amyloid and tau PET imaging with genomics and proteomics significantly advances our understanding of the biological mechanisms underlying Alzheimer’s disease, fostering greater awareness of dementia’s complexity and paving the way for improved diagnosis, prognosis, and personalized care.